key: cord-0968934-450r5q1e
authors: Maldonado Slootjes, Sofia; Hammer, Frank; Leempoel, Jonathan; Peeters, André
title: Acute stroke care during the COVID-19 pandemic: difficult, but not impossible!
date: 2020-07-07
journal: Acta Neurol Belg
DOI: 10.1007/s13760-020-01422-2
sha: 941d9d226ca84f23309e9af08ca6cb30841f7342
doc_id: 968934
cord_uid: 450r5q1e

nan

neurological symptoms resolved as reflected by a NIHSS of 1 at 72 h after symptom onset.

In a health care system overwhelmed by COVID-19 patients, acute stroke management represents a major challenge. Awareness of stroke symptoms may be reduced, patients are experiencing fear of hospitals and stay at home, although they require urgent medical attention, while inhospital logistical pathways have changed. For instance, PPE regulations have been implemented to reduce nosocomial infection rate, which has been reported to be as high as 41.3% [2] . However necessary, they may prove to be timeconsuming in a code stroke setting. Despite these difficulties, successful outcome may be achieved, such as in our case. Since cerebrovascular disease has been observed in 5.9% of COVID-19 patients [3] , this situation will not be infrequent. The implementation of protected code stroke is, therefore, essential [1, 4, 5] . Treating patients early after symptom onset remains the cornerstone of stroke management and stroke physicians should continue to pursue this goal during the COVID-19 pandemic.

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Fig. 1 a Persistent right carotid T occlusion despite initiation of intravenous alteplase, with no visualization of the middle and anterior cerebral arteries. b Complete recanalization of the right carotid artery (mTICI grade 3) after first-pass thrombus aspiration

Protected code stroke. Hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study

Acute stroke management pathway during Coronavirus-19 pandemic

Endovascular therapy for patients with acute ischemic stroke during the COVID-19 pandemic